JAMA Internal Medicine study examines the safety of GLP-1 receptor agonists and other second-line antidiabetic medications during early pregnancy, finding no significant increase in congenital anomalies compared to insulin use.
Newer diabetes drugs do not increase fetal risk
How safe are GLP-1R agonists in early pregnancy?
Targeting the GLP-1 Receptor: Genetics and a New Option for Weight Loss
Consensus Recommendations on GLP-1 RA Use in the Management of Type 2 Diabetes Mellitus: South Asian Task Force
BREAKING! U.S. FDA Study Discovers That Diabetics Taking GLP-1 Receptor Agonists Drugs Have Higher Risk Of Acute Cholecystitis And Death! - Thailand Medical News
Glucagon-like peptide 1 receptor agonists: cardiovascular benefits and mechanisms of action
IJMS, Free Full-Text
How glucagon-like peptide 1 receptor agonists work in: Endocrine Connections Volume 10 Issue 7 (2021)
Midwives need more support to deliver advice on alcohol consumption in pregnancy
:max_bytes(150000):strip_icc()/GettyImages-538882863-e51a40e5b8da40ce82e98e79576e7230.jpg)
